#1blocker vs refine 2017 pdf

GOVERNMENT CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS). OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT reassignment NATIONAL INSTITUTES OF HEALTH (NIH), U.S. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US201662361474P priority Critical Application filed by University of California filed Critical University of California Priority to US15/648,423 priority patent/US10711312B2/en Assigned to NATIONAL INSTITUTES OF HEALTH (NIH), U.S. Original Assignee University of California Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Antoni Ribas Jesse Zaretsky Daniel Shin Angel Garcia-Diaz Blanca Homet Moreno Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US15/648,423 Other versions US20180051347A1

#1blocker vs refine 2017 pdf

Google Patents Methods for immunotherapy-based treatment and assessment of cancerĭownload PDF Info Publication number US10711312B2 US10711312B2 US15/648,423 US201715648423A US10711312B2 US 10711312 B2 US10711312 B2 US 10711312B2 US 201715648423 A US201715648423 A US 201715648423A US 10711312 B2 US10711312 B2 US 10711312B2 Authority US United States Prior art keywords endogenous cancer jak2 jak1 loss Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US10711312B2 - Methods for immunotherapy-based treatment and assessment of cancer US10711312B2 - Methods for immunotherapy-based treatment and assessment of cancer